Silencing Nrf2 in cisplatin resistant non-small cell lung cancer cells augments sensitivity towards EGFR inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silencing Nrf2 in cisplatin resistant non-small cell lung cancer cells augments sensitivity towards EGFR inhibitor

Published:2024-12 Issue: Volume:101 Page:105921
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Fouzder Chandrani,Mukhuty Alpana,Chattopadhyay Dipanjan,Das Snehasis,Hira Sumit Kumar,Kundu Rakesh

Funder

Science and Engineering Research Board

University Grants Commission

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Reference42 articles.

1. Resistance mechanism to cisplatin in NCI-H460 non-small cell lung cancer cell line: investigating apoptosis, autophagy, and cytogenetic damage;Ballestreri;Cancer Drug Resist.,2018

2. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature;Barr;PLoS One,2013

3. The Nrf2cell defence pathway: Keap1-dependent and-independent mechanisms of regulation;Bryan;Biochem. Pharmacol.,2013

4. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC;Chang;Lung Cancer,2011

5. New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment;Chen;Int. J. Mol. Sci.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP